Correlation Between Avax Techs and Lipella Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Avax Techs and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avax Techs and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Avax Techs and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on Avax Techs and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avax Techs with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avax Techs and Lipella Pharmaceuticals.

Diversification Opportunities for Avax Techs and Lipella Pharmaceuticals

0.76

Correlation Coefficient

Avax Techs  Lipella Pharmaceuticals

Poor diversification

The 3 months correlation between Avax and Lipella is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Avax Techs and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and Avax Techs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avax Techs are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of Avax Techs i.e., Avax Techs and Lipella Pharmaceuticals go up and down completely randomly.

Pair Corralation between Avax Techs and Lipella Pharmaceuticals

Given the investment horizon of 90 days Avax Techs is expected to under-perform the Lipella Pharmaceuticals. In addition to that, Avax Techs is 1.57 times more volatile than Lipella Pharmaceuticals Common. It trades about -0.13 of its total potential returns per unit of risk. Lipella Pharmaceuticals Common is currently generating about 0.02 per unit of volatility. If you would invest  334.00  in Lipella Pharmaceuticals Common on September 4, 2024 and sell it today you would lose (29.00) from holding Lipella Pharmaceuticals Common or give up 8.68% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Avax Techs  vs.  Lipella Pharmaceuticals Common

Avax Techs

Risk-Adjusted Performance

0 of 100

OK

Over the last 90 days Avax Techs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Lipella Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Lipella Pharmaceuticals Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Lipella Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Avax Techs and Lipella Pharmaceuticals

The main advantage of trading using opposite Avax Techs and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avax Techs position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.

The idea behind Avax Techs and Lipella Pharmaceuticals Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.